A detailed history of Nj State Employees Deferred Compensation Plan transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 38,000 shares of VKTX stock, worth $2.83 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
38,000
Previous 8,700 336.78%
Holding current value
$2.83 Million
Previous $713,000 182.47%
% of portfolio
0.26%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$47.39 - $80.2 $1.39 Million - $2.35 Million
29,300 Added 336.78%
38,000 $2.01 Million
Q1 2024

May 02, 2024

BUY
$17.4 - $94.5 $151,380 - $822,150
8,700 New
8,700 $713,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.71B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Nj State Employees Deferred Compensation Plan Portfolio

Follow Nj State Employees Deferred Compensation Plan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.